# Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation

Study · id `cardio:ct-nct03433274` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03433274](<https://clinicaltrials.gov/study/NCT03433274>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03433274

Browse, organ or system: Heart  
Browse, condition area: Heart failure; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 103 participants.

## Technical summary

Registry record NCT03433274. Randomized; no masking; primary purpose treatment. Start 2018-06-15 (actual); primary completion 2024-04-29 (actual). Results posted on 2026-01-08.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 103 participants (enrolled count; ClinicalTrials.gov record NCT03433274, source copy `cardio:ctgov-nct03433274-2026-07-23`, retrieved 2026-10-26)
- Started: 2018-06-15 (actual) (ClinicalTrials.gov record NCT03433274, source copy `cardio:ctgov-nct03433274-2026-07-23`, retrieved 2026-10-26)
- Primary completion: 2024-04-29 (actual) (ClinicalTrials.gov record NCT03433274, source copy `cardio:ctgov-nct03433274-2026-07-23`, retrieved 2026-10-26)
- Completion: 2028-06 (anticipated) (ClinicalTrials.gov record NCT03433274, source copy `cardio:ctgov-nct03433274-2026-07-23`, retrieved 2026-10-26)
- Results first posted: 2026-01-08 (ClinicalTrials.gov record NCT03433274, source copy `cardio:ctgov-nct03433274-2026-07-23`, retrieved 2026-10-26)
- Countries: United States; Canada (ClinicalTrials.gov record NCT03433274, source copy `cardio:ctgov-nct03433274-2026-07-23`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03433274-2026-07-23`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
- Acronym: SUMMIT
- Condition: Mitral Regurgitation
- Condition: Mitral Insufficiency
- Condition: Mitral Valve Insufficiency
- Condition: Cardiovascular Diseases
- Condition: Valve Disease, Heart
- Condition: Heart Valve Diseases
- Condition: Functional Mitral Regurgitation
- Condition: Degenerative Mitral Valve Disease
- Intervention (Device): Tendyne Mitral Valve System
- Intervention (Device): MitraClip System
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Mitral regurgitation (`cardio:mitral-regurgitation`)
- Registry intervention name matches this record: MitraClip (`cardio:mitraclip`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: 04d9b257ff5fe0fa33bfbc422b52eaa0bfc3e15a6372c7ec07c95fe300d3108c
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
